HCA Healthcare (NYSE:HCA) COO Jon Foster Sells 21,713 Shares of Company Stock

HCA Healthcare, Inc. (NYSE:HCA) COO Jon Foster sold 21,713 shares of HCA Healthcare stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $494.95, for a total transaction of $10,746,849.35. Following the completion of the transaction, the chief operating officer directly owned 10,000 shares in the company, valued at approximately $4,949,500. The trade was a 68.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

HCA Healthcare Price Performance

HCA opened at $494.44 on Friday. The business has a fifty day moving average price of $443.66 and a 200 day moving average price of $445.25. The stock has a market capitalization of $103.28 billion, a price-to-earnings ratio of 16.38, a PEG ratio of 1.56 and a beta of 1.11. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.65 by $0.57. The business had revenue of $19.85 billion during the quarter, compared to analyst estimates of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The business’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.96 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 30.15 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 10.34%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of HCA. BlackRock Inc. bought a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $5,069,974,000. Legal & General Group Plc acquired a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $410,992,000. Jupiter Topco LLC bought a new position in shares of HCA Healthcare in the second quarter valued at approximately $371,138,000. Wellington Management Group LLP raised its holdings in shares of HCA Healthcare by 20.5% in the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after purchasing an additional 799,761 shares during the period. Finally, Bank of America Corp DE bought a new stake in shares of HCA Healthcare during the second quarter valued at about $238,457,000. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. UBS Group decreased their price objective on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a report on Monday, July 27th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a report on Friday, October 2nd. The Goldman Sachs Group reduced their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a report on Tuesday, July 28th. Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 14th. Finally, Leerink Partners restated an “outperform” rating and issued a $492.00 price objective on shares of HCA Healthcare in a research note on Friday, September 18th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $480.13.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Investors have welcomed expectations that a Democratic-controlled Congress could provide a policy tailwind for hospitals. However, the anticipated relief is not yet enacted and still depends on legislative and funding steps. HCA Healthcare Gains Policy Tailwind
• Positive Sentiment: HCA is expanding AI tools, with its nurse handoff technology heading to 100 hospitals and ambient AI expected to reach 10,000 physicians by year-end. These deployments could support workflow efficiency. AI nurse handoff tool
• Positive Sentiment: Analyst and technical coverage is supportive: Truist reaffirmed its Buy rating, while Zacks highlighted earnings growth, price strength and a bullish moving-average signal. Truist reaffirms Buy rating Zacks stock outlook
• Neutral Sentiment: HCA completed a $6.5 billion senior notes offering. The report confirms the financing but gives limited detail on its use or effect on borrowing costs. Senior notes offering
• Neutral Sentiment: HCA’s AI chief emphasized that delaying a rollout can be appropriate, suggesting a measured approach that may limit near-term adoption while managing implementation risks. HCA AI rollout strategy
• Negative Sentiment: One report flagged potential payer pressure in HCA’s 2027 outlook, a concern for future hospital reimbursement and margins. Payer pressure outlook
• Negative Sentiment: Pomerantz LLP said it is investigating investor claims involving HCA. The announcement provides no findings, but the inquiry may create a legal overhang. Investor investigation announcement

HCA Healthcare Company Profile

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine.

The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices.

Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.